Contribution of the ArsRS Two-Component System and HomB to Helicobacter pylori Biofilm Formation
Abstract
Discovery of H. pylori within the human stomach not only defied the dogma that the human stomach was a sterile environment, but also revolutionized the treatment of gastric and duodenal ulcers. Moreover, H. pylori became the first, and only, bacterium to be classified as a class I carcinogen. While, treatment of H. pylori infection leads to beneficial outcomes with respect to incidence of peptic ulcer disease and gastric cancers, treatment failure following H. pylori eradication therapy can be as high as 20 ; rates of resistance continue to rise. For a pathogen in which a two-week course of triple or quadruple therapy is already the current recommendation, the need for a better treatment regimen is evident.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 08, 2016
- Accession Number
- AD1127813
Entities
People
- Stephanie L. Servetas
Organizations
- Uniformed Services University of the Health Sciences